Say Hello to Thailand

Alvogen Thailand

53 Sivayathorn Tower
12th Floor, Wireless Road
Lumpini, Phatumwan
Bangkok 10330, 

(66)2 105 0199
(66)2 105 0198

Alvogen has an office in Bangkok, with a current team of five people. The team is led by Peter Keil, the EVP of Sales & Marketing in the APAC region. Current focus is on Portfolio Management and DRA activities to build up the necessary product range and infrastructure for further growth. Alvogen’s approach in Thailand is to continue registrations of new products and gradually build up product offering through partnerships and strategic portfolio acquisitions.

"The Thai pharmaceutical market is undergoing fundamental changes opening up opportunities for imported quality generics. However, tough regulatory hurdles (such as mandatory local BE studies and climate zone IV stability data) and strong local competition demand careful portfolio evaluation.

We plan to launch launch 25 products throughout the APAC region in 2012 and continue to strenghten our local team", says Peter Keil, EVP of Sales & Marketing in the APAC region (excluding China).

Market info

Pharmaecutial market

The total pharmaceutical market is valued at approx. $3.3 billion and is expected to grow at a compound annual growth rate of 9.1% in the period 2009-2014 (IMS market prognosis). Generic penetration is approx. 25% in value and 70% in volume terms.

Generics market

While the generics market will grow in volume, it will become increasingly competitive. Generics are sold mainly as brands in Thailand. However, international non-proprietary names (INNs) are used for listings on the NLED and for prescribing in the public sector.

  • $3.3BTotal pharmaceutical
  • 25%Generics penetration
    in value
  • 9.1%Annual pharmaceutica
    market growth 2009-2014
  • 70%Generics penetration
    in volume